Navigation Links
Selected Value Therapeutics Exercises Right to Develop and Commercialize ENMD-2076 in China
Date:6/7/2011

ical Oncology (ASCO) annual meeting.  SVT's option exercise is an important milestone for the ENMD-2076 program and for EntreMed.  We are pleased with SVT's commitment and confidence in ENMD-2076's potential.  We look forward to working with SVT as the development of ENMD-2076 progresses in China and we work to determine the design of future clinical trials."  

About ENMD-2076

ENMD-2076 is an orally-active, Aurora A/angiogenic kinase inhibitor with a unique kinase selectivity profile and multiple mechanisms of action. ENMD-2076 has been shown to inhibit a distinct profile of angiogenic tyrosine kinase targets in addition to the Aurora A kinase. Aurora kinases are key regulators of mitosis (cell division), and are often over-expressed in human cancers. ENMD-2076 also targets the VEGFR, Flt-3 and FGFR3 kinases which have been shown to play important roles in the pathology of several cancers. ENMD-2076 has shown promising activity in Phase I clinical trials in solid tumor cancers, leukemia, and multiple myeloma.  ENMD-2076 is currently in a Phase 2 trial for ovarian cancer, and preclinical and clinical activities are ongoing in assessing the compound's applicability for other forms of cancer.

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company committed to developing ENMD-2076, a selective angiogenic kinase inhibitor, for the treatment of cancer.  ENMD-2076 is currently in a multi-center Phase 2 study in ovarian cancer and in several Phase 1 studies in solid tumors, multiple myeloma, and leukemia.  Additional information about EntreMed is available on the Company's web site at www.entremed.com and in various filings with the Securities and Exchange Commission (the SEC).

Forward Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Ac
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
2. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
3. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
4. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
5. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
6. XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention
7. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
8. Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
9. Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research
10. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
11. Sangamo BioSciences Announces Research Collaboration With UCLA in Human Stem Cells Selected to Receive Clinical Research Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 2015 According to a new ... (Integrated, Standalone), by Deployment Mode (Web based, On-Premise, Cloud-Based), ... Service Providers), by Component - Global Trends & Forecast ... estimated at $501.1 Million 2014, and is projected to ... 7.6% from 2014 to 2019. Browse ...
(Date:8/27/2015)... , Aug. 27, 2015  BioElectronics Corporation (OTC Pink: BIEL), ... that three abstracts featuring the use of ActiPatch®, its ... 9 th Congress of the European Pain Federation ... September 2015. The Company will also be exhibiting ... Gianluca Bagnato , department clinical and experimental rheumatology ...
(Date:8/27/2015)... YORK , Aug. 27, 2015   Americord ... cord tissue , and placenta tissue banking ... cord blood banking e-commerce website. This new website makes ... ever with an interactive shopping cart and checkout process. ... "Most cord blood banking websites make this service ...
Breaking Medicine Technology:Radiology Information Systems Market Worth $722.7 Million by 2019 2Radiology Information Systems Market Worth $722.7 Million by 2019 3Radiology Information Systems Market Worth $722.7 Million by 2019 4BioElectronics Selected to Present its Pain Research and Devices at the European Pain Federation Conference 2Cord Blood Bank Revolutionizes Process of Online Cord Blood Banking 2
... PhotoMedex, Inc. (Nasdaq: PHMD ) announced ... current clinical trial being performed by John Y.M. Koo, ... of California, San Francisco. Dr. Koo,s experimental treatment protocol ... from moderate to severe psoriasis. The study, which utilizes ...
... Awarepoint Corporation announced today that CEO Jay Deady will ... Healthcare Innovation Summit on April 14, 10:30 a.m. – ... York. Joining Deady on the panel will be Harry Greenspun, ... Safavi, M.D., vice president and global lead of the Cisco ...
Cached Medicine Technology:Clinical Trial Offers New Hope for Moderate to Severe Psoriasis Sufferers 2Clinical Trial Offers New Hope for Moderate to Severe Psoriasis Sufferers 3Awarepoint CEO Jay Deady to Serve as Panelist at IBF's Digital Healthcare Innovation Summit 2Awarepoint CEO Jay Deady to Serve as Panelist at IBF's Digital Healthcare Innovation Summit 3
(Date:8/27/2015)... ... August 27, 2015 , ... Workflow in labs has greatly ... in the last decade. New features such as multiplexing, microfluidics, and integration ... where do lab managers, technicians, and researchers find handy metrics to compare and ...
(Date:8/27/2015)... CA (PRWEB) , ... August 27, 2015 , ... According ... and the American Heart Association have released new guidelines to educate doctors and patients ... last update to these particular guidelines came in 2007, so the new version is ...
(Date:8/27/2015)... ... 2015 , ... Thriveology Founders, Dr. Carly Letzt Carney and Dr. Mark Carney ... in Denver, Colorado on Saturday, August 29, 2015 at the Marriott DTC, 4900 S. ... health authorities, and will present a two part seminar entitled, “How to Thrive as ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... exploding legal marijuana industry with the launch of its Doobster platform, a HIPAA-compliant ... to order products from their smart phones and tablets. Well, Doobster, “The ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... Hurricane Katrina slammed into the Gulf Coast, killing more than 1,800 people, displacing ... according to a Georgia State University study. , While most people don’t develop ...
Breaking Medicine News(10 mins):Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 2Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 3Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 2Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 3Health News:Internationally-renowned Naturopathic Doctor and Chiropractor Team up to Reveal Secrets of Avoiding Disease 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 3Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 4Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 5Health News:About 10 Percent of Mothers Experienced Depression Two Years After Hurricane Katrina, New Study Shows 2
... change habits, but social shame works even better, suggests a ... disease rates blamed on the microbial pathogens that cause diarrhea ... workers there just beating their heads against the reality of ... to change it," said Subhrendu Pattanayak, an associate professor at ...
... Unlike other forms of suicide, physician assisted death does ... among surviving family members. In addition, the prevalence and ... loved ones received aid in dying is no different ... physician assisted suicide. These findings are the result of ...
... ... Administration (USFDA) will host Assessing Benefits and Risks of Medicinal Products in Regulatory Decisions from ... ... (DIA) and the US Food and Drug Administration (USFDA) will host Assessing Benefits ...
... researchers , WEDNESDAY, Sept. 30 (HealthDay News) -- Non-AIDS-related ... more common among HIV patients than among people without ... to treat people with the virus, U.S. researchers say. ... are at increased risk for so-called AIDS-defining malignancies, which ...
... to 49 are 19 times more likely to have memory ... Former professional football players suffer from Alzheimer,s disease or other ... a new study commissioned by the National Football League shows. ... 49 are 19 times more likely to struggle with memory ...
... ... selected Water For People to provide technical support for a 31-million-euro initiative funded by ... drinking water and improved sanitation to more than 540,000 people in 21 low-income areas ... ...
Cached Medicine News:Health News:Peer pressure builds more latrines than financial assistance 2Health News:Peer pressure builds more latrines than financial assistance 3Health News:Physician-assisted suicide does not increase severity of depression, grief among family members 2Health News:Global Regulators to Discuss Benefit-Risk Approaches of Medicinal Products at DIA Workshop 2Health News:Global Regulators to Discuss Benefit-Risk Approaches of Medicinal Products at DIA Workshop 3Health News:Non-AIDS-Related Cancers Growing Among HIV Patients 2Health News:Dementia Risk Higher for NFL Players 2Health News:Dementia Risk Higher for NFL Players 3Health News:Dementia Risk Higher for NFL Players 4Health News:Dementia Risk Higher for NFL Players 5Health News:Dementia Risk Higher for NFL Players 6Health News:Water For People Selected for $1.56 Million Project in Africa 2Health News:Water For People Selected for $1.56 Million Project in Africa 3Health News:Water For People Selected for $1.56 Million Project in Africa 4
QualCraft™ Euro Lite has a molded nylon frame that fits most faces. Universal keyhole nose bridge fits narrow to average noses. Available with or without lead vinyl-lined side shields....
QualCraft™ Radiation-Reducing Eyewear is 50% lighter than other protective eyewear. Manufactured for the ultimate combination of comfort, function, and protection....
Clip-On Glasses clip onto regular eyewear frames. Plano (nonprescription) only. Will not fit over high-plus or high-minus presciptions, or over glasses with thick frames. Black wire frames. Wt. 63 g....
Portable shields for your safety and convenience....
Medicine Products: